A procedure for addressing the soil-abutment interaction problem in the safety assessment of bridges

Autor: Carbonari, S., Dezi, F., Martini, R., Brunetti, A., Leoni, G.

Publikováno v: In Soil Dynamics and Earthquake Engineering January 2025 188 Part A

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses.

Autor: Rexhepaj M; Department of Biochemistry, University of Washington, Seattle, WA, USA., Asarnow D; Department of Biochemistry, University of Washington, Seattle, WA, USA., Perruzza L; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland., Park YJ; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Guarino B; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland., Mccallum M; Department of Biochemistry, University of Washington, Seattle, WA, USA., Culap K; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland., Saliba C; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland., Leoni G; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland., Balmelli A; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland., Yoshiyama CN; Department of Biochemistry, University of Washington, Seattle, WA, USA., Dickinson MS; Department of Biochemistry, University of Washington, Seattle, WA, USA., Quispe J; Department of Biochemistry, University of Washington, Seattle, WA, USA., Brown JT; Department of Biochemistry, University of Washington, Seattle, WA, USA., Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Sprouse KR; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA., Taylor AL; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA., Corti D; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland., Starr TN; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address: tyler.starr@biochem.utah.edu., Benigni F; Humabs Biomed SA, a Subsidiary of Vir. Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: fbenigni@vir.bio., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA. Electronic address: dveesler@uw.edu.

Publikováno v: Immunity [Immunity] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.

Integrating multidisciplinary instruments for assessing coastal vulnerability to erosion and sea level rise: lessons and challenges from the Adriatic Sea, Italy

Autor: Bonaldo, D., Antonioli, F., Archetti, R., Bezzi, A., Correggiari, A., Davolio, S., De Falco, G., Fantini, M., Fontolan, G., Furlani, S., Gaeta, M. G., Leoni, G., Presti, V. Lo, Mastronuzzi, G., Pillon, S., Ricchi, A., Stocchi, P., Samaras, A. G., Scicchitano, G., Carniel, S.

Publikováno v: Journal of Coastal Conservation, 2019 Feb 01. 23(1), 19-37.

Externí odkaz: https://www.jstor.org/stable/45047987

Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.

Autor: D'Alise AM; Nouscom Srl, Rome, Italy., Leoni G; Nouscom Srl, Rome, Italy., Cotugno G; Nouscom Srl, Rome, Italy., Siani L; Nouscom Srl, Rome, Italy., Vitale R; Nouscom Srl, Rome, Italy., Ruzza V; Nouscom Srl, Rome, Italy., Garzia I; Nouscom Srl, Rome, Italy., Antonucci L; Nouscom Srl, Rome, Italy., Micarelli E; Nouscom Srl, Rome, Italy., Venafra V; Department of Biology, University of Rome 'Tor Vergata,' Rome, Italy., Gogov S; Nouscom AG, Basel, Switzerland., Capone A; Nouscom Srl, Rome, Italy., Runswick S; Nouscom AG, Basel, Switzerland., Martin-Liberal J; Catalan Institute of Oncology (ICO), Barcelona, Spain., Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Moreno V; START Madrid-FJD, Hospital Fundacion Jimenez Díaz, Madrid, Spain., Symeonides SN; Edinburgh Experimental Cancer Medicine Centre, University of Edinburgh, Edinburgh, United Kingdom., Scarselli E; Nouscom Srl, Rome, Italy., Bechter O; Leuven Cancer Institute, Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jun 03; Vol. 30 (11), pp. 2412-2423.